Search clinical trials for: carfilzomib, lenalidomide plus dexamethasone
Total 538 results
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
Wake Forest University Health SciencesCelgene; Amgen; Janssen, LPActive, not recruitingMultiple MyelomaUnited States
-
University Hospital, ToulouseCelgene; Onyx Therapeutics, Inc.UnknownMultiple MyelomaFrance
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Austrian Forum Against CancerUnknownMultiple Myeloma Light Chain Induced Renal InsufficiencyAustria, Czech Republic
-
AmgenCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
University of ChicagoActive, not recruitingMultiple MyelomaUnited States, Poland
-
Institut de Cancérologie de la LoireCelgene CorporationCompletedLeukemia, Lymphoid | Precursor B-Cell Lymphoblastic Leukemia-LymphomaFrance
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, France, Australia
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompletedMultiple MyelomaGermany
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
TJ Biopharma Co., Ltd.Active, not recruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseChina, Taiwan
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingSmouldering MyelomaNetherlands, Norway, Czechia, Italy
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Fondazione Italiana Linfomi ONLUSActive, not recruiting
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
International Myeloma FoundationJanssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Oslo University HospitalNordic Myeloma Study GroupActive, not recruitingMyelomaNorway, Denmark, Sweden
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
Dong-A University HospitalAmgenNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
Universitätsklinikum Hamburg-EppendorfActive, not recruiting
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | New Diagnosis TumorItaly
-
Nantes University HospitalActive, not recruiting
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, Germany, Belgium, Denmark, Greece, France, United States, Ukraine, Poland
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedPlasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Myeloma, Plasma-CellIsrael
-
National Cancer Institute (NCI)Celgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States